BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38606828)

  • 21. Analysis of failures in patients with FIGO stage IIIc1-IIIc2 endometrial cancer.
    Gadducci A; Cosio S; Fabrini MG; Guerrieri ME; Greco C; Genazzani AR
    Anticancer Res; 2012 Jan; 32(1):201-5. PubMed ID: 22213308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer.
    Lum MM; Belnap TW; Frandsen J; Brown AP; Sause WT; Soisson AP; Dodson MK; Werner T; Gaffney DK
    Am J Clin Oncol; 2015 Jun; 38(3):283-8. PubMed ID: 23774072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification.
    Mutch D; Gaffney D; Matias-Guiu X; Fotopoulou C; Concin N; Berek JS;
    Int J Gynaecol Obstet; 2024 Jun; 165(3):1304-1305. PubMed ID: 38512105
    [No Abstract]   [Full Text] [Related]  

  • 24. A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma.
    Onal C; Sari SY; Yildirim BA; Yavas G; Gultekin M; Guler OC; Akyurek S; Yildiz F
    J Gynecol Oncol; 2019 May; 30(3):e28. PubMed ID: 30887753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the National Cancer Database.
    Nieto K; Adams W; Pham N; Block AM; Grover S; Small W; Harkenrider MM
    Gynecol Oncol; 2018 Jan; 148(1):147-153. PubMed ID: 29129389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter to the Editor: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification.
    Segovia JM; Cantor EA; Vargas HA; Sanabria DE; Murillo JA; Gomez Botero L
    Int J Gynaecol Obstet; 2024 Jun; 165(3):1302-1303. PubMed ID: 38512068
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer.
    Ayhan A; Taskiran C; Celik C; Yuce K; Kucukali T
    Int J Gynecol Cancer; 2002; 12(5):448-53. PubMed ID: 12366661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of endometrial cancer.
    Fowler W; Mutch D
    Womens Health (Lond); 2008 Sep; 4(5):479-89. PubMed ID: 19072487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
    Milgrom SA; Kollmeier MA; Abu-Rustum NR; Tew WP; Sonoda Y; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Sep; 130(3):436-40. PubMed ID: 23800696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
    de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; Colombo A; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Carinelli S; Provencher D; Hanzen C; Lutgens LCHW; Smit VTHBM; Singh N; Do V; D'Amico R; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
    Lancet Oncol; 2018 Mar; 19(3):295-309. PubMed ID: 29449189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer.
    Goodman CR; Hatoum S; Seagle BL; Donnelly ED; Barber EL; Shahabi S; Matei DE; Strauss JB
    Gynecol Oncol; 2019 Apr; 153(1):41-48. PubMed ID: 30660345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
    Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
    Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).
    Chen JR; Chang TC; Fu HC; Lau HY; Chen IH; Ke YM; Liang YL; Chiang AJ; Huang CY; Chen YC; Hong MK; Wang YC; Huang KF; Hsiao SM; Wang PH
    Medicine (Baltimore); 2016 Apr; 95(15):e3330. PubMed ID: 27082583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study.
    Forsse D; Barbero ML; Werner HMJ; Woie K; Nordskar N; Berge Nilsen E; Ellstrøm Engh M; Vistad I; Rege A; Sævik-Lode M; Andreasen S; Haldorsen IS; Trovik J; Krakstad C
    Am J Obstet Gynecol; 2022 Jan; 226(1):90.e1-90.e20. PubMed ID: 34400137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer?
    Boothe D; Orton A; Kim J; Poppe MM; Werner TL; Gaffney DK
    Am J Clin Oncol; 2019 Nov; 42(11):813-817. PubMed ID: 31592805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment outcomes and complications in FIGO stage IIIC and IVB endometrioid endometrial cancer patients presenting as nodal spreads following systematic lymphadenectomy and adjuvant therapy.
    Kong TW; Jo E; Son JH; Paek J; Chang SJ; Ryu HS
    J Obstet Gynaecol Res; 2021 Sep; 47(9):3322-3330. PubMed ID: 34196087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advanced endometrial carcinoma: primary debulking surgery or neoadjuvant chemotherapy?].
    Guyon F; Stoeckle E; Thomas L; Petit A; Sire M; Floquet A
    Bull Cancer; 2012 Jan; 99(1):43-9. PubMed ID: 22198346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.